CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH DYSCIRCULATORY ENCEPHALOPATHY

Download full text PDF
Issue: 
1
Year: 
2015

A. Firsov, Candidate of Medical Sciences N.P. Ogarev Mordovian State University, Saransk

The paper considers the results of using Pronoran in patients with dyscirculatory encephalopathy.

Keywords: 
cognitive impairments
dyscirculatory encephalopathy
Pronoran (piribedil)
cognitive functions



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Gavrilova S.I. Farmakoterapija bolezni Al'tsgejmera / M.: Pul's, 2003. Damulin I.V. Legkie kognitivnye narushenija // Consilium Medicum. – 2. 2004; 2: 149–53.
  2. Zaharov V.V. Vserossijskaja programma issledovanij epidemiologii i terapii kognitivnyh rasstrojstv v pozhilom vozraste («PROMETEJ») // Nevrologich. zhurn. – 2006; 11: 27–32.
  3. Zaharov V.V. Kognitivnye narushenija v nevrologicheskoj praktike // Trudnyj patsient. – 2005; 5: 15–8
  4. Zaharov V.V., Lokshina A.B. Primenenie preparata Pronoran (piribedil) pri legkih kognitivnyh rasstrojstvah u pozhilyh bol'nyh s distsirku-ljatornoj entsefalopatiej // Nevrol. zhurn. – 2004; 2: 30–5.
  5. Lokshina A.B., Zaharov V.V. Legkie i umerennye kognitivnye narushnija pri distsirkuljatornoj entsefalopatii // Nevrol. zhurn. – 2005; 11 (Pril. 1): 57–63.
  6. Simonenko V.B., Shirokov E.A. Preventivnaja kardionevrologija / SPb, 7. 2008.
  7. Suslina Z.A., Geraskina L.A., Fonjakin A.V. Arterial'naja gipertonija, sosudistaja patologija mozga i antigipertenzivnoe lechenie / M., 2006.
  8. Jahno N.N. Kognitivnye rasstrojstva v nevrologicheskoj klinike // Nevrol. zhurn. – 2006; Pril. 1: 4–12.
  9. Jahno N.N., Zaharov V.V. Legkie kognitivnye narushenija v pozhilom vozraste // Nevrol. zhurn. – 2004; 1: 4–8.
  10. Jahno N.N., Zaharov V.V., Lokshina A.B. Narushenija pamjati i vnimanija v pozhilom vozraste // Zhurn. nevrol. i psihiatr. – 2006; 2: 58–62.
  11. Jahno N.N., Lokshina A.B., Zaharov V.V. Legkie i umerennye kognitivnye rasstrojstva pri distsirkuljatornoj entsefalopatii // Klin. gerontol. – 2005; 11: 38–9.
  12. Jahno N.N., Preobrazhenskaja I.S. Pronoran v lechenii bol'nyh s rannimi stadijami bolezni Parkinsona // Nevrologich. zhurn. – 2004; 9 (6): 34–8.
  13. Cacciatore F., Abete P., Ferrara N. et al. The role of blood pressure in 14. cognitive impairment in an elderly population // J. Hypertension. – 2002; 15: 135–42.
  14. Dufouil C., Chalmers C., Coskun O. et al. Effects of blood pressure lowering 15. on cerebral white matter hyperintensities in patients with stroke. The PROGRESS (Pcrindopril Protection against Recurrent Stroke Study) magnetic resonance imaging substudy // Circulation. – 2005; 1 (12): 1644–50.
  15. Jelic V., Kivipelto M., Winblad B. Clinical trials in mild cognitive impairment: 16. lessons for thefuture // J. Neurol. Neurosurg. Psychiat. – 2006; 77 (7): 892.
  16. Knopman D. Current treatment of mild cognitive impairment and Alzheimer's 17. disease // Cur. Neurol. Nerosci. Rep. – 2006; 6 (5): 365–71.
  17. Kurshner H. Mild cognitive impairment: to treat or not to treat? // Cur. Neurol. Neurosci. Rep. – 2005; 5 (6): 455–7.
  18. Lithell H., Hansson L., Skoog I. et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial // J. Hypertens. – 2003; 21: 875–86.
  19. Nagaraia D., Jayashree S. Randomised study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment // Am. J. Psychiat. – 2001; 158 (9): 1517–9.
  20. Nasreddine Z., Phillips N., Bodirian V. et al. The Montreal Cognitive . Assessment (MoCA): A Brief Screening Tool For Mild Cognitive Impairment // J. Am. Geriatr. Soc. – 2005; 53: 695–9.
  21. Reisberg B. Global measures: utility in defining and measuring treatment response in dementia // Int. Psychoger. – 2007; 19 (3): 421–56.